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Abstract. Loss of p53 tumor suppressor facilitates acquisition
of telomerase activity. In fact, both p53 inactivation and
telomerase activation are frequently found in human cancers.
p53 inactivation, however, eliminates or attenuates the
biological responses to telomerase inhibition and the eventual
telomere erosion. We show that telomere erosion can
increase the susceptibility to radiation, irrespective of p53
status. Both telomerase inhibition and critically shortened
telomere with significant change of chromosomal end-to-end
fusion were essential for the enhancement of radiosensitivity.
The enhancement was correlated with greater formation of
multinucleated cells. p53 inactivation did not eliminate the
observed generation of chromosomal fusion and multi-
nucleation, and the resulting increased susceptibility to
radiation, as opposed to the previously proved role of p53 in
mediating cellular responses to telomere dysfunction. The
present findings suggest the importance of chromosomal
end fusion in modulating radiosensitivity rather than p53
DNA damage signaling. Thus, the suggested anticancer
radiotherapeutic strategy combined with telomerase inhibition
could clinically be applicable to cancers, irrespective of p53
status.
Introduction
One goal in modern cancer radiotherapies is to design a
sensitizing agent to enhance the radiotherapeutic efficacy for
cancer treatment with minimum cytotoxic effect on the normal
cells. In this respect, telomerase is an attractive molecular
target, since its activity has been found in >85% of human
cancers, however, it is absent in most normal somatic tissues
(1,2). 
Due to the lack of telomerase activity, most normal somatic
cells lose telomeric repeats after each cell division, and their
telomeres eventually reach a level that activates p53 tumor
suppressor to cease cell proliferation, termed replicative
senescence (3,4). Deletion of p53 allows continued cellular
proliferation beyond this Hayflick limit (5), thereby resulting
in further severe telomere shortening and eventual erosion of
one or more chromosomes (6,7). Interestingly, p53 involvement
in biological response to telomere dysfunction has been
found where p53 inactivation alleviates reproductive organ
apoptosis against shortened telomeres (8) and abrogates
cellular apoptosis to deprotected telomeres due to the loss of
TRF2 telomere binding protein (9). In addition, p53 inactivation
alters biological response type to telomere erosion (10,11).
These findings underline that p53 is a key mediator of cellular
responses to telomere dysfunction and plays an essential role
in the maintenance of genomic stability related to telomere
structure. Besides mediating telomere dysfunction, p53 also
participates in repressing telomerase expression (12). Actually,
p53 inactivation and telomerase activation are widespread
alterations in human cancers (13,14) and these two factors
can affect double-strand DNA repair pathways which maintain
genomic stability (15,16). Therefore, a therapeutic approach
which utilizes telomerase inhibition should consider the effect
of p53 loss.
Late generation telomerase null mouse (mTERC-/-) and
primary cultured normal cells have increased radiosensitivity
and an impaired double-strand DNA repair response upon
exposure to ionizing radiation (15). To exploit this telomerase
inhibition strategy for clinical application, it is necessary to
consider that transformed tumor cells often exhibit highly
differential responses against radiation when compared to
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untransformed primary cultured cells. A systematic analysis
of radiosensitivity using genetically defined p53 null cells
revealed that, although no significant differential radio-
sensitivity exists between untransformed p53-/- and p53+/+
MEFs, the transformation makes p53+/+ MEFs extremely
sensitive against radiation, unlike p53-/- MEFs (17). Therefore,
it is important to evaluate the relative contribution of
telomerase inactivation in telomerase-positive tumor cells,
compared to normal somatic cells. Furthermore, it is provoc-
ative to investigate whether telomerase inhibition can evoke
radiosensitization of transformed tumor cells lacking p53
function, since p53 loss is thought to abrogate cellular response
to telomere dysfunction (8,9,11,15,16). In the present study,
employing Myc/Ras-transformed MEFs derived from both
mTERC-/-INK4a-/- and mTERC-/-p53-/- mice (8,18), we
investigated the functional relation of p53 and telomere
dysfunction in modulating radiation response, by comparing
their radiosensitivity profiles with the genomic instabilities
via structural changes of telomere repeat. Contrary to earlier
evidence that p53 is an extremely important factor in exhibiting
cellular responses to telomere dysfunction, we found that p53
was not linked to enhancement of radiosensitivity resulting
from chromosomal end-to-end fusions due to critically short
telomere.
Materials and methods
Generation of transformed mTERC-/- MEFs. The Myc/Ras-
transformed MEFs derived from mice carrying homozygous
deletions of mTERC, and either the INK4a or p53 locus were
obtained as described previously (8,18,19). The INK4a-/-
mTERC-/- and mTERC-/-p53-/- MEFs, grown in DMEM
containing 10% FBS, were co-transfected with 2 μg each of
expression constructs for Myc and H-RASG12, and either
mTERC (20) or an empty Bluescript KS(+) (Stratagene)
vector. The resulting single clones were picked, expanded 14
days after the transfection, and passaged until 220 population
doubling levels (PDL). These passaged single clones were
mixed in the same ratio at the indicated passage numbers
according to each genotype. Serial passages of individual
clones obtained from late generation were performed at
confluence with a split ratio of 1:16 (corresponding to four
population doublings).
Determination of cell survival and viability. The survival of
transformed MEFs was determined by measuring the colony-
forming ability of single cells exposed to radiation. Cells were
seeded in triplicate at a density of 2,400 cells per 10-cm culture
dish, and were exposed to Á-ray using a 137Cs source, and the
resulting colonies formed 8 days after the radiation were
stained with 0.1% crystal violet for 30 min. The relative cell
survivals were calculated as percentages of colonies counted
in unirradiated cohorts.
For the determination of relative radiation sensitivity
between transformed and untransformed MEFs with critically
short telomeres, Myc/Ras-transformed G5 mTERC-/-INK4a-/-
and G6 mTERC-/-p53-/- MEFs were transfected with retroviral
pMFG-GFP (21) and selected with puromycin (3.0 μg/ml).
These GFP-labeled transformed MEFs were co-incubated
with untransformed normal G6 mTERC-/- MEFs at early
passages within PDL 20, irradiated with 0, 3, 6, and 8 Gy,
and the survived cells were then observed under fluorescence
microscope (x100) 5 days after the radiation.
Cytogenetic analysis. For metaphase preparation, the cells were
incubated with 0.1 μg/ml colcemid for 1 h, with hypotonic
0.075 M KCl for 20 min, and then fixed with a mixture of
methanol and acetic acid (3:1 vol/vol). The fixed cells dropped
onto slides were then baked at 60˚C for 2 h and stained with
Giemsa. To perform the fluorescence in situ hybridization
(FISH) of metaphase chromosome, air-dried slides were
fixed with 4% formamide/PBS and then hybridized to Cy3-
labeled telomere-specific (CCCTAA)3 peptide nucleic acid
probe, and counterstained with 4',6'-diamidino-2-phenylindole
(DAPI) as described previously (18). The frequency of
chromosomal end-to-end fusions was determined by counting
50 metaphases per sample.
Measurement of telomere length. Telomere length deter-
mination was performed on early and long-term passaged cells
as described previously (20). Briefly, cells embedded in agarose
plugs at a concentration of 1x106 cells per plug were treated
with proteinase K. The extracted DNA embedded in plugs
was digested with HinfI and RsaI and then electrophoresed
through 1% agarose gel in 0.5X TBE buffer at 14˚C, using a
ramped pulse speed of 1-6 sec at 6 V/cm for 17 h with CHEF
MAPPER DR III pulsed-field gel electrophoresis apparatus
(Bio-Rad). The gel was blotted and hybridized with telomeric
oligonucleotide probe (CCCTAA)3 and subsequently with
mouse major satellite repeat probe (GGACCTGGAATA
TGGCGAGAAA) (22). Telomere length was presented as
mean telomeric restriction fragment length (TRF), which was
calculated as previously defined (23).
Measurement of mitotic death. Mitotic cell death after radiation
was determined by counting the cells with multinuclei as
described previously (24). Cells growing at low density on
slide glass were exposed to radiation doses indicated on the
text, and the irradiated cells were fixed after 5 days in 70%
methanol for 1 h and stained with either hematoxylin/eosin or
DAPI. The percentages of cells with multinuclei or micronuclei
(≥3) were determined by counting at least 200 cells for each
sample under light and fluorescence microscopes.
Results
Both telomerase inhibition and short telomeres are required for
the enhancement of radiosensitivity, which can occur irre-
spective of p53 status. The serial intercrosses of mTERC-/-
mice lacking tumor suppressor INK4a or p53 produce mice
with progressively shortened telomere (8,18). However, these
two compound mutant mice exhibit different phenotypes with
the emergence of telomere dysfunction. These differences
result mainly from their p53 status principally due to DNA
damage, since INK4a-/- null mice retain functional p53 against
DNA damage, including anticancer agents and radiation
(25,26, and data not shown). Thus, the responses against telo-
mere dysfunction according to p53 status, especially resulting
from DNA damage, could systemically be elucidated by
comparing cells derived from these two compound mutant
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mice. In this study, we initially assessed the radiosensitivity
of Myc/Ras-transformed MEFs which were derived from
mTERC-/-INK4a-/- mice. These transformed MEFs grew
rapidly in culture and formed the tumors on nude (data not
shown) and SCID mice (18). Myc/Ras-transformed late
generation G5 mTERC-/-INK4a-/- MEFs have chromosomal
end-to-end fusions, whereas these same cells that have
been reconstituted with mouse telomerase RNA component
(mTERC) have minimal chromosomal aberrations (18).
Therefore, these comparable sets of G5 transformed MEFs
with or without mTERC-reconstitution are useful to examine
the contribution of telomerase inactivation of telomerase-
positive tumor cells, maintaining critically short telomeres,
in evaluating cellular response to radiation. Myc/Ras trans-
formation leads to gross genetic changes that are distinct
from parental cells and differ among the individual clones;
therefore, these resulting clones would be expected to differ
in their sensitivity to radiation. To exclude such bias as clonal
variation due to Myc/Ras transformation, we examined radiation
sensitivity in two differently prepared pooled transformed
populations: one was a mixture of individually isolated clones
expanded in culture, designated as clonal pool or clonal pooled
population, and the other was a mixture of whole clones formed
in one MEF culture pooled together, designated as whole
pool or whole pooled population. Reconstitution of mTERC
affected both growth and survival rates of G5 mTERC-/-NK4a-/-
cultures. The growth rates of the mTERC-reconstituted pools
were higher than those of the corresponding pools without
mTERC-reconstitution, irrespective of pooling methods (data
not shown). In a survival analysis, the mTERC-reconstitution
exerted a profound effect on radiation resistance of G5
mTERC-/-INK4a-/- cultures (Fig. 1A), indicating that telomerase
inactivation can elicit an enhancement of radiation sensitivity
in telomerase-positive transformed cells. Since rapidly growing
cancer cells are generally considered to be more sensitive to
radiation than slowly growing cancer cells, we could reasonably
exclude the possibility that the faster growth by mTERC-
reconstitution resulted in the radiation resistance in our
survival analysis. Specifically, the mTERC-/- clonal pools
showed an average 2.32-fold lower survival rate to 3 Gy of
radiation than the corresponding mTERC-reconstituted
pools, which was evidently found in all three clonal pooled
populations (Fig. 1A, 11.1% vs 24.3% for G5.1; 9.1% vs
21.6% for G5.2; and 9.5% vs 22.9% for G5.3). This observation
was further supported by comparison of radiosensitivities in
pools composed of whole clones. The mTERC-/- whole pool,
designated as G5.3W in Fig. 1A, also exhibited a lower
survival rate than that of the mTERC-reconstituted whole
pool. In all experiments using Myc/Ras-transformed pooled
populations, the telomerase-reconstituted G5 mTERC-/-INK4a-/-
MEF cultures exhibited a survival rate comparable to that of
mTERC+/+INK4a-/- MEF culture (Fig. 1A, hatched bar).
Next, to address whether the influence of p53 loss on the
observed radiosensitivity profile was dependent on telomerase
status, we investigated the radiotherapeutic efficacy of telo-
merase inhibition using Myc/Ras-transformed mTERC-/-p53-/-
MEFs. Similar to those seen in G5 mTERC-/-INK4a-/- MEF
cultures, the whole pools mixed with all the clones formed in
one G6 mTERC-/-p53-/- MEF culture were more radiosensitive
than those of the corresponding mTERC-rescued pools, as
shown in all three independently isolated whole pools (Fig. 1B;
G6.1W, G6.2W, and G6.3W). Further support of this
enhanced radiosensitivity came from the comparison of
radiosensitivities between the clonally isolated pool of G6
mTERC-/-p53-/- clones (n=10) and that of the mTERC-rescued
clones (n=5) (Fig. 1B, G6). These clonally isolated pools also
exhibited a radiosensitivity profile similar to that seen in all
three whole pools. The present findings illustrate that mTERC-
reconstitution exerts a profound effect on the responses of G6
mTERC-/-p53-/- cultures to radiation, similar to G5 mTERC-/-
INK4a-/- cultures. However, the mTERC-reconstitution did
not affect the survival rates of early generation G1 mTERC-/-
INK4a-/- or G2 mTERC-/-p53-/- cultures which retain intact
telomere function (8,18) (Fig. 1), suggesting that critically
short telomere as well as telomerase inhibition are required
to elicit an enhanced radiosensitivity of telomerase-positive
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Figure 1. Enhanced radiosensitivity of Myc/Ras-transformed late generation
telomerase-deficient MEFs, irrespective of p53 status. Survivals of Myc/Ras-
transformed pooled populations of telomerase-deficient MEF cultures with
(closed bars) and without mTERC reconstitution (open bars), and telomerase-
proficient MEF cultures (hatched bar) were measured 8 days after exposure
to 3 Gy of radiation. (A) Pooled populations of Myc/Ras-transformed G5 and
G1 mTERC-/-INK4a-/- MEFs were prepared by mixing individually isolated
clones derived from G5 and G1 MEFs (G5.1, 13 and 10 clones; G5.2, 10 and 8
clones; G5.3, 8 and 6 clones; G1, 10 and 10 clones with and without mTERC-
reconstitution, respectively) and by mixing whole clones formed in one culture
dish, which was derived from G5.3 MEFs (G5.3W). Pool of Myc/Ras-
transformed mTERC+/+INK4a-/- MEF culture was composed of 10 clones
isolated individually. (B) Pooled populations of Myc/Ras-transformed G6
and G2 mTERC-/-p53-/- MEFs were prepared by mixing whole clones
formed in one 10-cm culture dish, which was derived from three G6 MEFs
and one G2 MEF (G6.1W, G6.2W, G6.3W, and G2W), and in one set of
individually isolated clones derived from G6.1 MEFs (5 and 10 clones with
and without mTERC reconstitution, respectively). Pools of Myc/Ras-
transformed mTERC+/+p53-/- MEF culture were composed of independently
derived whole clones.
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tumor cells. In addition, the lower survival rates found in
both G5 mTERC-/-INK4a-/- and G6 mTERC-/-p53-/- cultures
than their corresponding mTERC-reconstituted cultures clearly
indicate that telomerase inhibition can sensitize telomerase-
positive cells with critically short telomeres toward radiation,
and that this sensitization could occur regardless of p53 status,
due to DNA damage response.
Correlation of radiosensitization level with the degrees of
genomic instability represented by chromosomal end fusion.
To further evaluate the observed enhancement of radio-
sensitivity by telomerase inhibition, Myc/Ras-transformed G5
mTERC-/-INK4a-/- clones (10 clones with and 8 clones without
mTERC-reconstitution) and Myc/Ras-transformed G6
mTERC-/-p53-/- clones (5 clones with and 10 clones without
mTERC-reconstitution) were passaged until PDL 220. These
four sets of the individual clones with and without telomerase
reconstitution were mixed by their genotypes at early, middle,
and late passages (PDL 20, 80 or 140, and 220, respectively)
in the same ratio to make genotype-matched clonal pools,
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Figure 2. Correlation between radiosensitivity, chromosomal end-to-end fusion and telomere length as a function of cell division. The individual clones of
Myc/Ras-transformed G5 mTERC-/-INK4a-/- (n=8) and G5 mTERC-/-INK4a-/-[+mTERC] MEFs (n=10), and the individual clones of Myc/Ras-transformed G6
mTERC-/-p53-/- (n=10) and G6 mTERC-/-p53-/-[+mTERC] MEFs (n=5) were passaged until PDL 220, and the respective genotype-matched clones were mixed to
prepare pooled clonal populations at three steps during the passages as indicated in the panels. (A and B) Telomere lengths analyzed by Southern blot analysis of
terminal restriction fragment (TRF). The blots of digested DNA were probed with telomeric repeat (CCCTAA)3 or major satellite DNA described in Materials and
methods. +, the telomere lengths of cells with mTERC-reconstitution; -, the telomere lengths of cells without mTERC-reconstitution. (C and D) Chromosomal
end-to-end fusions measured by counting 50 metaphases per clone. (E and F) Survivals measured after exposure to 3 Gy of radiation. In C-F  closed bars
indicate addition of mTERC, open bars the addition of empty vector, and hatched bars no addition.
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and then the correlations between radiosensitivity and either
telomere length or chromosomal end-to-end fusions were
investigated. As shown in Fig. 2A and B, increasing passages
of G5 mTERC-/-INK4a-/- and G6 mTERC-/-p53-/- MEF cultures
during the period of PDL 20 to 220 led to a progressive
shortening of telomere length (Δ119 bp and Δ74.5 bp per PD,
respectively). As the telomere shortened during the passages,
both cultures exhibited concomitant increase of chromosomal
end-to-end fusions (Δ0.021 and Δ0.019 fusions per PD,
respectively) (Fig. 2C and D), where the telomere signals
were not detectable at the fusion points by fluorescence in situ
hybridization with telomeric repeat probe (Supplementary
Fig. 1). On the contrary to telomerase-deficient cultures,
however, the mTERC-reconstituted cultures did not show
reduction of telomere lengths (Fig. 2A and B) and showed
negligible changes in the number of chromosomal end-to-end
fusions (Fig. 2C and D) during the passages. The remarkable
increase of telomere length in the mTERC-reconstituted G6
mTERC-/-p53-/- pool was found to be due to the increase of
only one out of five clones, however, long-term passages of
this clone did not affect the survival rate (data not shown), thus
eliminating possible bias in the evaluation of the mTERC-
reconstituted pool. The significantly reduced telomere length
and increased chromosomal end-to-end fusions, shown in both
mTERC-/-INK4a-/- and mTERC-/-p53-/- cultures, but not in the
mTERC-reconstituted cultures, illustrate that telomerase-
deficient cultures are accompanied with increasing genomic
instability, represented by chromosomal end-to-end fusions
during long-term passages, whereas telomerase-reconstituted
cultures maintain the genomic stability with nearly the same
amounts of initial fusions.
Next, using these pools with differential genomic instability
according to passage numbers, we analyzed survival rates to
find out whether there was any correlation between radio-
sensitivity and either telomere length or chromosomal end-
to-end fusions. Increasing passages of both mTERC-/-INK4a-/-
and mTERC-/-p53-/- pools led to decreased survivals after the
exposure to radiation (Fig. 2E and F). Specifically, the initial
11.8% and 34.5% survivals of G5 mTERC-/-INK4a-/- and G6
mTERC-/-p53-/- MEFs at PDL 20 decreased gradually to 2.3%
and 18.2% at PDL 220, respectively. Comparing dose-response
curves of mTERC-/- and mTERC-reconstituted cells at PDL
220, we found marked difference in survival fractions between
the G5 mTERC-/-INK4a-/- or G6 mTERC-/-p53-/- MEF culture
and the corresponding mTERC-rescued culture (Supplementary
Fig. 2). The gradual reduction of survivals according to the
degree of chromosomal end-to-end fusions and telomere
shortening indicates that the genomic instability generated by
this chromosomal end fusion which resulted from telomere
shortening might be the basis of sensitization in telomerase-
deficient cells to radiation.
Abundant mitotic death in telomere dysfunctional cells. In
response to radiation, severely damaged cancer cells undergo
mitotic cell death which is characterized by the formation
of micronuclei and/or multinuclei (24,27). Critically short
telomere during mitosis often leads to bridge-breakage-fusion
cycle of telomeric fusion and impairment of G2/M check-
point control, which may be one mechanistic basis of the
generation of aneuploidy and polyploidy population (28,29).
In order to evaluate whether the reduced survival rate of
telomere dysfunctional cells after exposure to radiation might
have been due to mitotic cell death, we examined the formation
of micronuclei and multinuclei.
Myc/Ras-transformed G5 mTERC-/-INK4a-/- and G6
mTERC-/-p53-/- cells and their corresponding mTERC-rescued
cells showed a dose-dependent increase of multinuclei (n≥3)
upon exposure to radiation, however, micronuclei were rarely
generated even in high-dose radiation (data not shown). In
our transformed MEF cultures, the most prominent feature
was an appearance of enlarged cells containing multiple nuclei
within a cell, determined by both hematoxylin/eosin and DAPI
stainings (Fig. 3A), which could optimally be assessed 5 days
after the exposure to radiation. In addition, the changing
pattern of multinucleation after the exposure to radiation was a
gradual increase of number of multinuclei in both G5 mTERC-/-
INK4a-/- and G6 mTERC-/-p53-/- cultures, accompanied by a
reduction of diploid population (Fig. 3B and C). Under a steady
growing condition, G5 mTERC-/-INK4a-/- and G6 mTERC-/-
p53-/- cells and their mTERC-rescued cells maintained very
low levels of <0.1% multinuclei (Fig. 3D and E). Upon the
exposure to radiation, however, both G5 mTERC-/-INK4a-/-
and G6 mTERC-/-p53-/- cultures produced significantly more
multinuclei at PDL 20 than their corresponding mTERC-
rescued cultures (Fig. 3D and E). Specifically, G5 mTERC-/-
INK4a-/- cells and the mTERC-rescued cells produced 19.7%
and 11.0% of multinuclei (p=0.0026) at 6 Gy, respectively
(Fig. 3D). The significantly enhanced formation of radiation-
induced multinuclei was also evident in G6 mTERC-/-p53-/-
cells at PDL 20, compared to the mTERC-rescued cells [21%
vs 14% at 6 Gy, respectively (p=0.0015)] (Fig. 3E). These
findings indicate that abundant formation of multinuclei in
the telomere dysfunctional cells can occur irrespective of p53
status. This view was further strengthened by the observation
that increasing passages up to PDL 220 led to an increasing
formation of multinuclei in both G5 mTERC-/-INK4a-/- and
G6 mTERC-/-p53-/- cells, but not in the corresponding mTERC-
rescued cells. Similar to unchanged survival rates of early
generation cultures despite the mTERC-reconstitution, shown
in Fig. 1, there were no discernible differences in radiation-
induced multinuclei production between Myc/Ras-transformed
G1 mTERC-/-INK4a-/- or G2 mTERC-/-p53-/- cultures with
maintaining robust telomere function, and their corresponding
mTERC-rescued cultures. The above findings clearly show
that the reduction of survival rates and resulting enhancement
of radiosensitivity were due to more abundant mitotic death
of cells with genomic instability represented by chromosomal
end fusions, which is part of telomere dysfunction, than cells
with robust telomere function.
Relative contribution of telomerase deficiency in transformed
and untransformed cells with critically shortened telomere. For
clinical application of telomerase inhibition strategy, it is
important to consider that telomere shortening, as occuring
normally with age, would be expected to place normal tissues
of elderly patients at increased risk of enhanced radiosensitiz-
ation. Therefore, we can not exclude the possibility that normal
cells of older patients would be more radiosensitive than their
telomerase-inhibited tumor cells, thus losing any advantage of
telomerase inhibition with increasing age. To clarify this point,
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we investigated radiation sensitivity by culturing transformed
late generation telomerase-deficient culture together with
untransformed normal late generation telomerase-deficient
culture, both of which retained a critically short telomere
length with a significant amount of chromosomal end-to-
end fusions. As shown in Fig. 4, transformed G5 mTERC-/-
INK4a-/- and G6 mTERC-/-p53-/- cultures labeled with GFP
were seen under fluorescence microscope before irradiation,
however, after irradiation with more than 6 Gy, they completely
disappeared, even in the presence of untransformed normal
G6 mTERC-/- cells which do not form tumor mass on SCID
or nude mouse skin (20). In survival analyses, both Myc/Ras-
transformed G5 mTERC-/-INK4a-/- and G6 mTERC-/-p53-/-
cultures also exhibited lower survival rates, compared to those
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Figure 3. Increased multinuclei formation in telomere dysfunctional cells by radiation. The multinuclei formation of Myc/Ras-transformed mTERC-/-INK4a-/-,
mTERC-/-p53-/- cultures (open bars), and their corresponding mTERC-rescued cultures (closed bars) were counted 5 days after exposure to 6 Gy of radiation.
(A) Representative photographs showing radiation-induced mitotic cell death, determined by either hematoxylin/eosin (upper) or DAPI staining (bottom) of G5
mTERC-/-INK4a-/- cultures which were exposed to 0 and 6 Gy of radiation (magnification x200). Cells with multinuclei (≥3 per cell) were measured by
hematoxylin/eosin staining and confirmed by DAPI staining under a light and fluorescence microscope, respectively, by counting 200 cells/sample. (B and C)
Changing pattern of multinuclei number after exposure to 6 Gy of radiation. (D and E) Difference of multinucleated cell numbers between short-term (PDL 20)
and long-term (PDL 220) passaged cells.
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of their corresponding untransformed cultures (Supplementary
Fig. 3). These late generation transformed telomerase-deficient
cultures exhibited levels of telomere lengths and chromo-
somal end-to-end fusions comparable to their corresponding
untransformed normal cultures (Supplementary Fig. 4 and
data not shown). The present findings obtained from mixed
cultures of transformed and untransformed cultures, both of
which maintained critically shortened telomere length with
significant chromosomal end-to-end fusions, suggest that,
although normal tissues of older individuals would possibly
be expected to have increased radiation sensitivity due to
telomere shortening over cellular replication time, the radio-
sensitivity combined with telomerase inhibition would result
in significant therapeutic gain.
p53 inactivation did not alter radiosensitization mediated by
telomerase inhibition. To further confirm the present finding
that the observed enhancement of radiosensitivity occurred,
irrespective of p53 status, we generated telomerase-deficient
and -rescued transformed foci of G5 mTERC-/-INK4a-/- cultures
whose p53 could be inactivated by cotransfecting dominant
negative p53 with either Myc/Ras or Ras. The co-transfection
of Ras and KH215, a dominant negative mouse p53, leads to
more abundant formation of transformed foci through p53 in-
activation than that of Ras alone (30), which we also confirmed
in our present transformed foci analysis using G5 mTERC-/-
INK4a-/- MEFs (data not shown). As shown in Myc/Ras-
transformed G5 mTERC-/-INK4a-/- cells, Ras-transformed
telomerase-deficient cells were also more radiosensitive than
those with mTERC-reconstitution (Fig. 5). The introduction of
KH215 did not affect the observed differential radiosensitivity
profile between them, which was also found in Myc/Ras-
transformed G5 mTERC-/-INK4a-/- cells with and without
mTERC-reconstitution. We then examined whether viral
oncoproteins interacting with and inactivating p53 might
influence the observed radiosensitivity profile, and found that
G5 mTERC-/-INK4a-/- cells cotransfected with Ras and either
Ela (31) or SV40 Large T antigen (32) were more radio-
sensitive than their corresponding transformed cells with
mTERC-reconstitution. The chromosomal end-to-end fusions
were also found in these telomerase-deficient cells transformed
with viral oncogene or dominant negative p53, but negligibly
in their corresponding mTERC-reconstituted cells (data not
shown). These findings obtained through the inactivation of
p53 by dominant negative p53 or viral oncogenes strongly
support the notion that telomerase inhibition and resulting
telomere dysfunction can radiosensitize telomerase-positive
tumor cells irrespective of p53 status.
Discussion
Based on the recent observation that telomerase is activated
in human cancers but inactivated in normal somatic tissues,
attempts have been made to develop a telomerase inhibitor
as an anticancer therapy (33,34). The present study demon-
strated the possibility that the combination radiotherapy with
telomerase inhibitor could clinically be applicable for the
enhancement of radiotherapeutic efficacy. Although the loss
of p53 has been shown to attenuate the adverse cellular effects
of telomere dysfunction (8,9,11), our results described herein
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Figure 4. Higher radiation sensitivity of transformed late generation
telomerase-deficient cells compared to untransformed late generation
telomerase-deficient cells. Myc/Ras-transformed G5 mTERC-/-INK4a-/- and
G6 mTERC-/-p53-/- cells labeled with retroviral GFP vector were co-
incubated with untransformed G6 mTERC-/- cells at an early passage
within PDL 20, irradiated with 0, 6 and 8 Gy, and then inspected under
fluorescence microscope (x100). Representative image pictures of co-
incubated experiments which received 6 Gy irradiation and observed under
light (left columns of A and B) or fluorescence filter (right columns) or both
images of which merged together (middle columns).
Figure 5. Radiosensitization by telomerase-deficiency, irrespective of p53
inactivation. Survivals of transformed G5 mTERC-/-INK4a-/- MEF cultures
with and without mTERC reconstitution, whose p53 was inactivated by
dominant negative p53 (KH215) or viral oncogene (E1a or SV40 Large T
antigen), were measured 8 days after exposure to 3 Gy of radiation.
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showed that dysfunctional telomeres could sensitize p53-
deficient cells as well as p53-proficient cells toward radiation.
The mechanistic basis of the enhanced radiosensitivity was
most likely due to the genomic instability, represented by
chromosomal end-to-end fusions following critical telomere
shortening. This conclusion was derived from our findings
described herein as well as other earlier observations. After co-
transfection of Myc/Ras with or without mTERC reconstitution,
the difference of telomere length was hardly detectable
initially between mTERC-/- and the corresponding mTERC-
rescued cells (present finding), whereas the chromosomal
end-to-end fusions were abundantly found initially in the
mTERC-/- cells, but were negligible in the mTERC-rescued
cells (8,18,19, and the present study), indicating the genomic
instability in mTERC-/- cells. In cells passaged for 200 PDLs,
markedly increased fusions were the prominent feature of
mTERC-/- cells, but not in mTERC-rescued cells, suggesting
that the loss of chromosomal end capping capacity by
telomerase inhibition is important to elicit enhanced radio-
sensitivity. Before clinically applying this combination radio-
therapy, however, more careful considerations are needed,
since cancers in most cases are recognized as diseases of the
elderly and the normal cells of elderly patients would be at an
increased risk of radiosensitization due to telomere shortening
with age. Indeed, shortened telomere causes severe impairment
of gastrointestinal tract exposed to radiation (15). Nevertheless,
the previous findings that human cancers have relatively shorter
telomere than their matched somatic or peripheral blood cells
(35,36), together with our present results of complete regression
of transformed late generation telomerase-deficient tumor
cells, even in the presence of untransformed late generation
telomerase-deficient normal cells upon exposure to 8 Gy
irradiation, would give significant therapeutic gain to clinical
application of our present combination radiotherapy with
telomerase inhibition.
Since p53 mutation is frequently found in human cancers
and abrogates opposing effects of telomere dysfunction (8,9),
it is necessary to consider weather this combination radio-
therapeutic strategy could be applicable to p53 mutant cancers.
In fact, p53 is up-regulated during processing various bio-
logical responses to telomere dysfunction, such as apoptosis,
senescence, and cardiac failure (37,38). Moreover, it has been
suggested that mutation of p53 or inactivation of telomerase
could generate secondary mutation through increasing genomic
instability during cell proliferation (39,40). In the present study,
however, the analysis of the long-term passaged telomerase-
deficient cells revealed that progressive telomere shortening
and concomitant chromosomal end-to-end fusions during cell
division occurred in both p53 DNA damage response-deficient
and -proficient cells. The comparison of radiosensitivity and
the degree of chromosomal end-to-end fusions showed a strong
correlation between radiosensitizing efficacy and genomic
instability irrespective of p53 status due to DNA damage
response. Furthermore, the fact that p53 inactivation did not
alter the radiosensitization effect of telomerase inhibition
strongly suggests that telomerase inhibition can sensitize
telomerase-positive tumor cells irrespective of p53 status. This
result also suggests that the genomic instability induced by
chromosomal end-to-end fusion is important in evoking the
sensitivity toward radiation rather than p53 signaling after
irradiation. Therefore, this combination anticancer radiotherapy
with telomerase inhibition could be applicable to cancers,
regardless of p53 mutation.
Previously, the therapeutic enhancement of doxorubicin
in telomere dysfunctional cells was proved to be due to
generation of multichromosomal fusions in which the p-arm
of one chromosome is connected to the q-arm of another
(19). In contrast to doxorubicin exposure, however, post-
radiation did not produce any multichromosomal fusion
(Supplementary Fig. 5), suggesting the possibility that the
mechanistic basis of radiosensitization by telomerase inhibition
is different from that of doxorubicin. Nevertheless, the more
massive chromosomal fragmentation of telomere dysfunc-
tional cells than telomerase-reconstituted cells seemed to be a
common occurrence upon exposure to radiation or doxorubicin.
In summary, the observations presented herein provide
an important rationale for understanding the mechanism
of response of telomere dysfunctional cells to radiation. To
accomplish the clinical therapeutic efficacy of telomerase
inhibitors, tumor cells should divide until the emergence of
telomere dysfunction, as seen by increased chromosomal
aberrations. The mass of solid tumor in some cases would
limit sufficient divisions required for generating telomere-
free chromosomes, which could be a problem for clinical
application of telomerase inhibition strategy. However,
recurrent tumors after radiotherapy or after surgical resection
of tumor burdens would potentially be targeted to achieve
the purpose of combination radiotherapy with telomerase
inhibitor, since the recurrent tumors might allow sufficient
division to generate telomere-free chromosomes. A more
precise relationship between telomere dysfunction and
responses to radiation in various types of human tumors
should be explored in order to achieve a successful outcome
of telomerase inhibitor-based radiation therapy.
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Supplementary Figure 1. Representative metaphase showing chromosomal end-to-end fusions, detected with TRF-FISH. Metaphase spreads of Myc/Ras-
transformed G5 mTERC-/-INK4a-/- MEFs with or without mTERC reconstitution (+mTERC or +vector, respectively) were proved with Cy-3-labeled telomere
specific (CCCTAA)3 peptide nucleic acid probe and counter-stained with DAPI. Cy-3-labeled telomeres and DAPI-stained chromosome images were overlaid on
triple band filter set (x1000), and then captured with a digital cooled CCD camera. The most observed type of fusion is chromosomal end-to-end fusion, but neither
telomeric fusion nor telomeric association were observed. Arrows indicate the fusion point between p-arms of two chromosomes.
Supplementary Figure 2. Dose response curves of telomerase-deficient cells with and without telomerase reconstitution. The pooled populations passaged until
PDL 220 as prepared in the legend of Fig. 2 were irradiated and survival rates were examined.
Supplementary Figure 3. Comparison of survival rates between transformed and untransformed late generation telomerase-deficient cells. Relative survival rates
of Myc/Ras-transformed and their corresponding untransformed G5 mTERC-/-INK4a-/- or G6 mTERC-/-p53-/- cultures, and untransformed G6 mTERC-/-
cultures were determined by trypan blue exclusion method 3 and 7 days after exposure to radiation. Representative survival data measured 7 days after
radiation were presented.
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Supplementary Figure 4. Comparison of telomere lengths of transformed and untransformed late generation telomerase-deficient MEFs determined by TRF-
Southern blot hybridization. Telomere lengths of G5 mTERC-/-INK4a-/- (lanes 1 and 2), G6 mTERC-/-p53-/- (lanes 3 and 4), and G6 mTERC-/- MEFs (lanes 5)
were measured by TRF-Southern blot hybridization. U and T, cells without and with Myc/Ras transformation, respectively. White bar on each lane indicates
the mean telomere length of individual clones.
Supplementary Figure 5. Formation of multi-chromosomal fusions by doxorubicin, but not irradiation. The incidence of multi-chromosomal fusions (A and B) and
chromosomal fragmentation (C and D) in response to 48 h of exposure to 0.5 μM doxorubicin or 6 Gy radiation in G5 mTERC-/-INK4a-/- and G6 mTERC-/-
p53-/- cells with or without mTERC reconstitution (closed bars or open bars, respectively).
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